Welcome to Dermbits! Watch short videos of KOLs answering your questions

thumbnail_dermbits-colorful.png

dermbits-colorful.png

Dermbits

Was the tolerability of tapinarof cream better for the trials?

Psoriasis

The interesting part about Dependerov cream was the adverse event reporting of folliculitis, which is, again, is it sterile? Is it infectious? Is there an issue with folliculitis? For me, the dose limiting response would not be an issue if folliculitis was in the area, and I barely saw any reporting of it. But again, I would probably caution patients on okay, watch for anything that goes to inflammatory area. Watch for anything that's dose limiting or any potential new rash in the distribution of treatment. For the most part, most of the patients who completed the trial of Topinorov also did well and did not have any dropouts. Even more so, there was very little symptomatic change with the reported issue of folliculites. But again, in the clinical research, everything gets reported, and that's why things were the way they are. So I would just watch for that.

Was the tolerability of tapinarof cream better for the trials?

Related CME